Exxon Mobil Corporation : Buy in the lower bound
Entry price | Target | Stop-loss | Potential |
---|
US$83.88 |
US$0 |
US$81.1 |
-100% |
---|
In early March, Exxon Mobil has announced an "investment plan" of $ 185 billion over the next five years to develop new energy bids in order to meet the strong demand growth. This represents capital expenditure of about $ 37 million a year.
From a fundamental viewpoint, Exxon is trading at a moderate level compared with competitors. Its “enterprise value/revenue” ratio is estimated at 0.8x for 2012 and the PER is 10.3x for the same period. According to Thomson Reuters’ consensus, the average target price is $93.9 which represents a potential of 13% compared to the current price.
Since early january, stock is within a trading range USD 83.5 / 87.5 and is characterized by low volatility. Besides, the share has several times broke through the lower bound of this range. The proximity of 100-days moving average could bolster up the share to the resistance.
Thus, it would be advisable for investors to buy the share next to the support of USD 83.5 in order to aim at USD 87.5. If the security drops below USD 81.5, this strategy will be cancelled.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.